# China NMPA Inspection - Dazhou Chaoyang Pharmaceutical Co., Ltd. - January 25, 2019

Source: https://www.globalkeysolutions.net/records/china_inspection/dazhou-chaoyang-pharmaceutical-co-ltd/723893a9-6e63-4090-902a-d59614d523b8/
Source feed: China

> China NMPA unannounced inspection for Dazhou Chaoyang Pharmaceutical Co., Ltd. published January 25, 2019. An unannounced inspection by the National Medical Products Administration Audit and Inspection Center was conducted on Dazhou Chaoyang Pharmaceutical 

---

## Details

- Record Type: CHINA_INSPECTION
- Title: Notification of Unannounced Inspection of Dazhou Chaoyang Pharmaceutical Co., Ltd.
- Company Name: Dazhou Chaoyang Pharmaceutical Co., Ltd.
- Publication Date: 2019-01-25
- Product Type: Drugs
- Summary: An unannounced inspection by the National Medical Products Administration Audit and Inspection Center was conducted on Dazhou Chaoyang Pharmaceutical Co., Ltd. from October 17-19, 2018, as part of the national drug distribution enterprise annual inspection plan. The inspection uncovered several serious violations of the "Good Supply Practice for Pharmaceutical Products" (GSP) regulatory framework. Key issues included the company's failure to truthfully issue invoices, leading to inconsistencies between invoices, accounts, goods, and payments, particularly for individual clinics and retail pharmacies. Additionally, the company did not provide mandatory pre-job training for new employees and failed to adequately verify sales records. Significant problems were identified with the computer systems, which could not guarantee data authenticity, accuracy, or traceability. Maintenance of automatic temperature and humidity monitoring equipment was also found to be inadequate. Furthermore, the company lacked essential import approval documentation for its compound codeine phosphate oral solution. As a result of these findings, the Sichuan Provincial Drug Administration revoked Dazhou Chaoyang Pharmaceutical Co., Ltd.'s GSP certification and initiated an investigation into suspected illegal and irregular business practices.

Company: https://www.globalkeysolutions.net/companies/dazhou-chaoyang-pharmaceutical-co-ltd/d8b5d8e1-57c1-4780-af37-2dd3dba6555a/
